Veeva unveiled an AI agent designed to speed clinical trial study configuration for its EDC and Data Quality System customers. Veeva said Study Builder ingests a study protocol and, using agentic AI with Anthropic’s Claude model and CDISC standards, can draft configurations for EDC forms and visit schedules in as little as 24 hours with human oversight. The company also said the plugin leverages CDISC Unified Study Definitions Model (USDM) to reuse existing standards and reduce deviations, positioning the tool as a practical workflow accelerant for sponsors using Veeva systems. Veeva plans to make Study Builder available to licensees starting in December. Separately, the broader adoption of AI in clinical operations remains a key area for efficiency gains, with implications for trial setup timelines and cost control as sponsors push to compress development cycles without weakening compliance.